Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma Meeting Abstract
| Authors: | Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S. |
| Abstract Title: | Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | immunotherapy; mesothelin; muc16 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S229 |
| Language: | English |
| ACCESSION: | WOS:000370365100373 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30010-7 |
| Notes: | Meeting Abstract: ORAL28.05 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
